Total Payments
$14,525
2024 Payments
$2,250
Companies
45
Transactions
789
Medicare Patients
7,112
Medicare Billing
$558,550
Payment Breakdown by Category
Food & Beverage$13,980 (96.3%)
Education$544.43 (3.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,980 | 780 | 96.3% |
| Education | $544.43 | 9 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,435 | 137 | $0 (2024) |
| Janssen Biotech, Inc. | $1,406 | 73 | $0 (2024) |
| DUSA Pharmaceuticals, Inc. | $987.06 | 4 | $0 (2019) |
| LEO Pharma Inc. | $690.68 | 39 | $0 (2024) |
| Galderma Laboratories, L.P. | $644.33 | 53 | $0 (2024) |
| Lilly USA, LLC | $599.93 | 37 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $597.90 | 31 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $572.00 | 32 | $0 (2024) |
| Incyte Corporation | $531.39 | 27 | $0 (2024) |
| Amgen Inc. | $528.57 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,250 | 115 | ABBVIE INC. ($504.70) |
| 2023 | $2,308 | 114 | ABBVIE INC. ($453.68) |
| 2022 | $1,656 | 90 | ABBVIE INC. ($466.29) |
| 2021 | $1,777 | 111 | AbbVie Inc. ($345.76) |
| 2020 | $1,369 | 78 | Janssen Biotech, Inc. ($208.74) |
| 2019 | $1,312 | 74 | AbbVie, Inc. ($210.31) |
| 2018 | $1,279 | 77 | AbbVie, Inc. ($140.59) |
| 2017 | $2,574 | 130 | DUSA Pharmaceuticals, Inc. ($961.28) |
All Payment Transactions
789 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.98 | General |
| Category: Dermatology | ||||||
| 12/02/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: DERMATOLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $29.36 | General |
| Category: Immunology | ||||||
| 11/23/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.87 | General |
| Category: Dermatology | ||||||
| 11/22/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: Immunology | ||||||
| 11/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.48 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Inflammation & Immunology | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Dermatology | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Dermatology | ||||||
| 10/17/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.67 | General |
| Category: Dermatology | ||||||
| 10/16/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: DERMATOLOGY | ||||||
| 10/15/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $31.79 | General |
| Category: DERMATOLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/03/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Immunology | ||||||
| 10/02/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $20.83 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,819 | 2,755 | $659,089 | $142,533 |
| 2022 | 19 | 1,794 | 2,706 | $508,635 | $145,096 |
| 2021 | 23 | 1,854 | 2,891 | $407,528 | $159,029 |
| 2020 | 17 | 1,645 | 2,491 | $334,814 | $111,892 |
Total Patients
7,112
Total Services
10,843
Medicare Billing
$558,550
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 323 | 443 | $162,790 | $36,683 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 424 | 522 | $135,108 | $29,212 | 21.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 162 | 227 | $72,659 | $16,644 | 22.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 194 | 224 | $64,336 | $13,510 | 21.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 206 | 272 | $51,831 | $9,935 | 19.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 72 | 131 | $18,813 | $4,880 | 25.9% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 18 | 20 | $17,470 | $4,252 | 24.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $21,958 | $4,241 | 19.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 52 | 52 | $16,935 | $3,556 | 21.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 25 | 33 | $16,779 | $3,350 | 20.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 133 | 612 | $11,436 | $2,899 | 25.4% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 17 | 18 | $13,469 | $2,865 | 21.3% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 16 | 17 | $13,562 | $2,199 | 16.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 57 | 57 | $9,173 | $2,130 | 23.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 14 | 17 | $8,153 | $1,953 | 24.0% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 16 | 19 | $13,389 | $1,934 | 14.4% |
| 69100 | Biopsy of ear | Office | 2023 | 13 | 14 | $3,887 | $798.16 | 20.5% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 16 | 16 | $4,207 | $784.12 | 18.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 15 | 15 | $3,133 | $709.67 | 22.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 314 | 444 | $128,108 | $36,676 | 28.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 412 | 495 | $102,591 | $28,270 | 27.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 203 | 231 | $53,691 | $14,521 | 27.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 144 | 179 | $45,787 | $13,363 | 29.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 207 | 254 | $39,203 | $9,483 | 24.2% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2022 | 13 | 25 | $20,304 | $7,753 | 38.2% |
About Dr. Kevin Karikomi, D.O
Dr. Kevin Karikomi, D.O is a Dermatology healthcare provider based in Westerville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376558932.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin Karikomi, D.O has received a total of $14,525 in payments from pharmaceutical and medical device companies, with $2,250 received in 2024. These payments were reported across 789 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($13,980).
As a Medicare-enrolled provider, Karikomi has provided services to 7,112 Medicare beneficiaries, totaling 10,843 services with total Medicare billing of $558,550. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Westerville, OH
- Active Since 07/30/2006
- Last Updated 07/08/2007
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1376558932
Products in Payments
- Levulan (Drug) $961.28
- SKYRIZI (Biological) $957.58
- RINVOQ (Biological) $704.16
- TREMFYA (Drug) $546.11
- DUPIXENT (Biological) $542.06
- TALTZ (Drug) $536.59
- OPZELURA (Drug) $531.39
- REMICADE (Biological) $455.53
- Humira (Biological) $383.97
- COSENTYX (Biological) $374.59
- Cimzia (Drug) $355.40
- STELARA (Biological) $346.95
- Otezla (Drug) $330.24
- EUCRISA (Drug) $308.36
- ADBRY (Biological) $293.99
- ENSTILAR (Drug) $261.23
- VTAMA (Drug) $254.33
- ORACEA (Drug) $213.71
- BOTOX (Biological) $204.49
- Enbrel (Biological) $198.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Westerville
Dr. Joshua Grosshandler, M.d, M.D
Dermatology — Payments: $378,447
Dermatology $378,447
Jess Demaria, Md, MD
Dermatology — Payments: $195,915
Dermatology $195,915
Dr. Brittany Dulmage, M.d, M.D
Dermatology — Payments: $18,054
Dermatology $18,054
Rosina Lin, M.d, M.D
Dermatology — Payments: $17,300
Dermatology $17,300
Jennifer Nash, M.d, M.D
Dermatology — Payments: $9,506
Dermatology $9,506
Sara Huff, Md, MD
Dermatology — Payments: $5,661
Dermatology $5,661